BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

163 related articles for article (PubMed ID: 3924388)

  • 1. The pathogenesis of infections owing to Pseudomonas aeruginosa using the burned mouse model: experimental studies from the Shriners Burns Institute, Cincinnati.
    Holder IA
    Can J Microbiol; 1985 Apr; 31(4):393-402. PubMed ID: 3924388
    [No Abstract]   [Full Text] [Related]  

  • 2. The contribution of exoproducts to virulence of Pseudomonas aeruginosa.
    Nicas TI; Iglewski BH
    Can J Microbiol; 1985 Apr; 31(4):387-92. PubMed ID: 2988728
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Virulence factors of Pseudomonas aeruginosa.
    Döring G; Maier M; Müller E; Bibi Z; Tümmler B; Kharazmi A
    Antibiot Chemother (1971); 1987; 39():136-48. PubMed ID: 3118780
    [No Abstract]   [Full Text] [Related]  

  • 4. Role of exotoxin A and elastase in the pathogenicity of Pseudomonas aeruginosa strain PAO experimental mouse burn infection.
    Wretlind B; Björklind A; Pavlovskis OR
    Microb Pathog; 1987 Jun; 2(6):397-404. PubMed ID: 3148812
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Combined host and specific anti-Pseudomonas-directed therapy for Pseudomonas aeruginosa infections in burned mice: experimental results and theoretic considerations.
    Holder IA; Neely AN
    J Burn Care Rehabil; 1989; 10(2):131-7. PubMed ID: 2496130
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Therapy of experimental Pseudomonas burn wound sepsis with ciprofloxacin and Pseudomonas immune globulin.
    Collins MS; Tsay GC; Hector RF; Roby RE; Dorsey JH
    Antibiot Chemother (1971); 1987; 39():222-32. PubMed ID: 3118784
    [No Abstract]   [Full Text] [Related]  

  • 7. [Significance of Pseudomonas aeruginosa virulence factors for acute and chronic Pseudomonas aeruginosa infections].
    Döring G
    Infection; 1987; 15 Suppl 2():S38-41. PubMed ID: 3112018
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Pathogenesis of Pseudomonas aeruginosa infections].
    Cotar AI
    Bacteriol Virusol Parazitol Epidemiol; 2009; 54(4):139-45. PubMed ID: 20923118
    [No Abstract]   [Full Text] [Related]  

  • 9. Active immunization using exotoxin A confers protection against Pseudomonas aeruginosa infection in a mouse burn model.
    Manafi A; Kohanteb J; Mehrabani D; Japoni A; Amini M; Naghmachi M; Zaghi AH; Khalili N
    BMC Microbiol; 2009 Feb; 9():23. PubMed ID: 19183501
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Contribution of exoenzyme S to the virulence of Pseudomonas aeruginosa.
    Nicas TI; Iglewski BH
    Antibiot Chemother (1971); 1985; 36():40-8. PubMed ID: 2988426
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Significance of Pseudomonas aeruginosa virulence factors in acute and chronic Pseudomonas aeruginosa infections].
    Döring G
    Infection; 1987; 15(1):47-50. PubMed ID: 3106228
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The role of proteases and exotoxin A in the pathogenicity of Pseudomonas aeruginosa infections.
    Wretlind B; Pavlovskis OR
    Scand J Infect Dis Suppl; 1981; 29():13-9. PubMed ID: 6797058
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Efficacies of alkaline protease, elastase and exotoxin A toxoid vaccines against gut-derived Pseudomonas aeruginosa sepsis in mice.
    Matsumoto T; Tateda K; Furuya N; Miyazaki S; Ohno A; Ishii Y; Hirakata Y; Yamaguchi K
    J Med Microbiol; 1998 Apr; 47(4):303-8. PubMed ID: 9568995
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Biochemical and genetic aspects of Pseudomonas aeruginosa virulence.
    Lory S; Tai PC
    Curr Top Microbiol Immunol; 1985; 118():53-69. PubMed ID: 2414071
    [No Abstract]   [Full Text] [Related]  

  • 15. Antigens of Pseudomonas aeruginosa and their use in immunoprophylaxis and immunotherapy.
    Stanislavsky ES; Dmitriev BA; Lányi B; Joó I
    Acta Microbiol Hung; 1985; 32(1):3-37. PubMed ID: 2412389
    [No Abstract]   [Full Text] [Related]  

  • 16. Protection against Pseudomonas aeruginosa infection in a murine burn wound sepsis model by passive transfer of antitoxin A, antielastase, and antilipopolysaccharide.
    Cryz SJ; Fürer E; Germanier R
    Infect Immun; 1983 Mar; 39(3):1072-9. PubMed ID: 6404817
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Proteolytic cleavage of exotoxin A from Pseudomonas aeruginosa: formation of an ADP-ribosyltransferase active fragment by the action of Pseudomonas elastase.
    Sanai Y; Morihara K; Tsuzuki H; Homma JY; Kato I
    FEBS Lett; 1980 Oct; 120(1):131-4. PubMed ID: 6254804
    [No Abstract]   [Full Text] [Related]  

  • 18. Effect of immunisation with Pseudomonas aeruginosa on gut-derived sepsis in mice.
    Matsumoto T; Tateda K; Miyazaki S; Furuya N; Ohno A; Ishii Y; Hirakata Y; Yamaguchi K
    J Med Microbiol; 1998 Apr; 47(4):295-301. PubMed ID: 9568994
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Characterization of a Pseudomonas aeruginosa transposon insertion mutant with defective release of exoenzymes.
    Lindgren V; Wretlind B
    J Gen Microbiol; 1987 Mar; 133(3):675-81. PubMed ID: 2821166
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Common virulence factors for bacterial pathogenicity in plants and animals.
    Rahme LG; Stevens EJ; Wolfort SF; Shao J; Tompkins RG; Ausubel FM
    Science; 1995 Jun; 268(5219):1899-902. PubMed ID: 7604262
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.